Waxman Seeks Phenylephrine NDAC Review; Cites Efficacy Concerns

Rep. Henry Waxman (D-Calif.) is calling for an FDA advisory panel to reconsider the efficacy of the nasal decongestant phenylephrine and re-evaluate its status as a monograph ingredient